Community post

Earlier this month we posted that Adaptive Phage Therapeutics received emergency FDA authorization to treat a group of COVID-19 patients in Texas with A. baumannii infections. Now, they've received expanded access authorization to use their phages to treat COVID-19 patients with bacterial infections nationwide.